HK1244215A1 - 包含富马酸二甲酯的药物基质制剂 - Google Patents

包含富马酸二甲酯的药物基质制剂 Download PDF

Info

Publication number
HK1244215A1
HK1244215A1 HK18103740.7A HK18103740A HK1244215A1 HK 1244215 A1 HK1244215 A1 HK 1244215A1 HK 18103740 A HK18103740 A HK 18103740A HK 1244215 A1 HK1244215 A1 HK 1244215A1
Authority
HK
Hong Kong
Prior art keywords
dimethyl fumarate
pharmaceutical compositions
present
matrix formulations
pharmaceutical matrix
Prior art date
Application number
HK18103740.7A
Other languages
English (en)
Chinese (zh)
Inventor
Shyam B. Karki
Peter ZAWANEH
Cheuk-Yui LEUNG
Yiqing Lin
Original Assignee
比奥根Ma公司
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 比奥根Ma公司 filed Critical 比奥根Ma公司
Publication of HK1244215A1 publication Critical patent/HK1244215A1/zh

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/225—Polycarboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/282—Organic compounds, e.g. fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/284—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone
    • A61K9/2846—Poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4808—Preparations in capsules, e.g. of gelatin, of chocolate characterised by the form of the capsule or the structure of the filling; Capsules containing small tablets; Capsules with outer layer for immediate drug release
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Emergency Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Inorganic Chemistry (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
HK18103740.7A 2014-11-19 2015-11-19 包含富马酸二甲酯的药物基质制剂 HK1244215A1 (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201462081907P 2014-11-19 2014-11-19
US62/081,907 2014-11-19
PCT/US2015/061448 WO2016081671A1 (en) 2014-11-19 2015-11-19 Pharmaceutical matrix formulations comprising dimethyl fumarate

Publications (1)

Publication Number Publication Date
HK1244215A1 true HK1244215A1 (zh) 2018-08-03

Family

ID=54838418

Family Applications (1)

Application Number Title Priority Date Filing Date
HK18103740.7A HK1244215A1 (zh) 2014-11-19 2015-11-19 包含富马酸二甲酯的药物基质制剂

Country Status (13)

Country Link
US (2) US20190083404A1 (https=)
EP (1) EP3220897A1 (https=)
JP (2) JP6901393B2 (https=)
KR (1) KR20170086053A (https=)
CN (2) CN113262205A (https=)
AU (2) AU2015349891B2 (https=)
CA (1) CA2967645A1 (https=)
EA (1) EA201791089A1 (https=)
HK (1) HK1244215A1 (https=)
IL (1) IL252105A0 (https=)
MA (1) MA40990A (https=)
MX (1) MX391400B (https=)
WO (1) WO2016081671A1 (https=)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2987895A1 (en) 2015-06-01 2016-12-08 Sun Pharmaceutical Industries Ltd. Pharmaceutical compositions of dimethyl fumarate
KR102714380B1 (ko) 2021-06-09 2024-10-11 강원대학교산학협력단 경구 투여용 나노입자 및 이의 제조방법
WO2023036702A1 (en) 2021-09-09 2023-03-16 It Pharmagus Limited Method for the manufacturing of a solid body as an oral dosage form of a pharmaceutical or a food supplement

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU781058B2 (en) * 1999-08-31 2005-05-05 Grunenthal Gmbh Delayed-action form of administration containing tramadol saccharinate
EP1886665A1 (en) * 2006-08-01 2008-02-13 Boehringer Ingelheim Pharma GmbH & Co. KG Gastro retentive delivery system
WO2010079222A1 (en) * 2009-01-09 2010-07-15 Forward Pharma A/S Pharmaceutical formulation comprising one or more fumaric acid esters in an erosion matrix
US20120165404A1 (en) * 2009-04-29 2012-06-28 Biogen Idec Ma Inc. Treatment of neurodegeneration and neuroinflammation
EP2678305A4 (en) * 2011-02-25 2015-11-04 Univ Johns Hopkins CHALCONE DERIVATIVES AS NRF2 ACTIVATORS
US20130158077A1 (en) * 2011-12-19 2013-06-20 Ares Trading S.A. Pharmaceutical compositions
NZ627980A (en) * 2012-02-07 2016-12-23 Biogen Ma Inc Pharmaceutical compositions containing dimethyl fumarate
AU2013305684B2 (en) * 2012-08-22 2016-11-24 Xenoport, Inc. Oral dosage forms of methyl hydrogen fumarate and prodrugs thereof
AR094277A1 (es) * 2012-12-21 2015-07-22 Biogen Idec Inc Derivados de fumarato sustituidos con deuterio
CN105369562B (zh) * 2014-08-28 2019-12-20 青岛海尔洗衣机有限公司 一种带有防衣物褪色提醒功能的洗衣机

Also Published As

Publication number Publication date
CA2967645A1 (en) 2016-05-26
EA201791089A1 (ru) 2017-11-30
MX2017006561A (es) 2018-02-21
AU2021204247A1 (en) 2021-07-22
AU2015349891A1 (en) 2017-05-25
IL252105A0 (en) 2017-07-31
JP2017534667A (ja) 2017-11-24
US20190083404A1 (en) 2019-03-21
CN107205942A (zh) 2017-09-26
JP6901393B2 (ja) 2021-07-14
US20190175510A1 (en) 2019-06-13
AU2015349891B2 (en) 2021-04-01
EP3220897A1 (en) 2017-09-27
WO2016081671A8 (en) 2016-07-21
CN113262205A (zh) 2021-08-17
MX391400B (es) 2025-03-21
WO2016081671A1 (en) 2016-05-26
JP2021152046A (ja) 2021-09-30
MA40990A (fr) 2017-09-26
KR20170086053A (ko) 2017-07-25

Similar Documents

Publication Publication Date Title
SI3224254T1 (sl) Substituirani indazoli, postopek njihove priprave, farmacevtske formulacije, ki jih vsebujejo in njihova uporaba za pripravo zdravil
EP3389628A4 (en) PHARMACEUTICAL FORMULATIONS OF MOUSE CHEESE TABLETS
EP3527200A4 (en) LENALIDOMIDE ORAL TABLET COMPOSITION
EP3175847A4 (en) Pharmaceutical composition containing leuprolide and having both immediate and sustained release properties
PH12016501841A1 (en) Immunosuppressant formulation
HK1259441A1 (zh) 包含btk抑制剂的制剂/组合物
EP3102585A4 (en) Boronic acid esters and pharmaceutical formulations thereof
EP3093023A4 (en) Pharmaceutical composition for cancer treatment and pharmaceutical preparation for cancer treatment containing same composition as active ingredient
EP3192875A4 (en) Sustained-release pharmaceutical composition for treating and preventing ophthalmic diseases
IL252897A0 (en) Indanyl compounds, pharmaceutical preparations and their medical uses
HUE049298T2 (hu) Szitagliptin tartalmú stabil gyógyszerészeti készítmények azonnali hatóanyag leadású tabletta formájában
IL273704A (en) Pharmaceutical bilayer tablet formulations
EP3167893A4 (en) Pharmaceutical composition containing spirulina maxima extract as active ingredient for preventing and treating retinal diseases
HK1244215A1 (zh) 包含富马酸二甲酯的药物基质制剂
WO2016063289A3 (en) Pharmaceutical tablet compositions comprising rifaximin
EP3144005A4 (en) Composition for preventing and treating male infertility, containing mixed herbal extract as active ingredient and use thereof
EP3497080A4 (en) PHARMACEUTICAL FORMULATIONS AND THEIR USE
HUE066387T2 (hu) Polimerizált gyógyszert tartalmazó gyógyszerészeti készítmény
IL250419A0 (en) Use of a pill/tablet/capsule of minocycline, plataconazole and atorvastatin in the treatment of multiple sclerosis
EP3219311A4 (en) Pharmaceutical composition comprising dabigatran etexilate, and preparation method, solid preparation and use thereof
EP3153163A4 (en) Pharmaceutical compound comprising 13 glycerides, formulation and application thereof
HK40013407A (en) Sulfoxyalkyl organonitro and related compounds and pharmaceutical compositions for use in medicine
EM43669380001S (sl) Farmacevtske tablete
HK40019053A (en) Pharmaceutical formulations comprising 5-chloro-n4
HK40009162A (en) Pharmaceutical formulations